These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26546027)

  • 1. Pembrolizumab: a new Drug That Can Induce Exacerbations of Psoriasis.
    Sahuquillo-Torralba A; Ballester-Sánchez R; Pujol-Marco C; Botella-Estrada R
    Actas Dermosifiliogr; 2016 Apr; 107(3):264-6. PubMed ID: 26546027
    [No Abstract]   [Full Text] [Related]  

  • 2. Rupioid psoriasis induced by pembrolizumab.
    Marti-Marti I; Gómez S; Riera-Monroig J; Carrera C; Mascaró JM
    Indian J Dermatol Venereol Leprol; 2020; 86(5):580-582. PubMed ID: 32719194
    [No Abstract]   [Full Text] [Related]  

  • 3. New Yellow Plaques in a Patient Taking Pembrolizumab.
    Massey PR; Jones KM; Fox MC
    JAMA Oncol; 2017 Jan; 3(1):119-120. PubMed ID: 27892986
    [No Abstract]   [Full Text] [Related]  

  • 4. Follicular psoriasis induced by pembrolizumab in a patient with advanced non-small-cell lung cancer.
    Scarfì F; Lacava R; Patrizi A; Tartari F; Ravaioli GM; Veronesi G; Lambertini M; Dika E
    Int J Dermatol; 2019 Aug; 58(8):e151-e152. PubMed ID: 30964199
    [No Abstract]   [Full Text] [Related]  

  • 5. Psoriasis caused by pembrolizumab treatment in advanced melanoma: A positive prognostic side effect?
    D'Erme AM; Fidanzi C; Janowska A; Allegrini G; Barbara C; Cupini S; Viacava P; Bagnoni G
    Dermatol Ther; 2021 Sep; 34(5):e15050. PubMed ID: 34212457
    [No Abstract]   [Full Text] [Related]  

  • 6. Inverse Psoriasiform Eruption During Pembrolizumab Therapy for Metastatic Melanoma.
    Totonchy MB; Ezaldein HH; Ko CJ; Choi JN
    JAMA Dermatol; 2016 May; 152(5):590-2. PubMed ID: 26675815
    [No Abstract]   [Full Text] [Related]  

  • 7. Psoriasis Induced by Vedolizumab.
    Sody E; Körber A
    Inflamm Bowel Dis; 2017 Feb; 23(2):E9-E11. PubMed ID: 28107281
    [No Abstract]   [Full Text] [Related]  

  • 8. Psoriasis onset with tocilizumab treatment for rheumatoid arthritis.
    Wendling D; Letho-Gyselinck H; Guillot X; Prati C
    J Rheumatol; 2012 Mar; 39(3):657. PubMed ID: 22383356
    [No Abstract]   [Full Text] [Related]  

  • 9. TNF-α inhibitor (adalimumab) induced psoriasis: a case report.
    Al-Mutairi A; Elkashlan M; Al-Fayed HM; Swayed M
    Australas J Dermatol; 2012 May; 53(2):157. PubMed ID: 22571571
    [No Abstract]   [Full Text] [Related]  

  • 10. Plaque Psoriasis Flare and Peripheral Edema in a Patient Treated With Atezolizumab.
    Santos-Juanes J; Munguía Calzada P; Álvarez Fernández C
    Actas Dermosifiliogr (Engl Ed); 2019 Jun; 110(5):410-411. PubMed ID: 30366590
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor necrosis factor-associated palmoplantar pustular psoriasis treated with interleukin 6 blocker.
    Younis S; Rimar D; Slobodin G; Rosner I
    J Rheumatol; 2012 Oct; 39(10):2055-6. PubMed ID: 23028035
    [No Abstract]   [Full Text] [Related]  

  • 12. Paradoxical flare of pustular psoriasis triggered by ustekinumab, which responded to adalimumab therapy.
    Hay RA; Pan JY
    Clin Exp Dermatol; 2014 Aug; 39(6):751-2. PubMed ID: 24984757
    [No Abstract]   [Full Text] [Related]  

  • 13. Psoriasis induced by anti-tumour necrosis factor therapy in patients with inflammatory bowel disease.
    Salgueiro P; Lago P; Pedroto I
    J Crohns Colitis; 2013 Sep; 7(8):e325-6. PubMed ID: 23352103
    [No Abstract]   [Full Text] [Related]  

  • 14. New-onset psoriasis associated with adalimumab: a report of two cases.
    Glenn CJ; Kobraei KB; Russo JJ
    Dermatol Online J; 2011 Sep; 17(9):15. PubMed ID: 21971280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
    Sansó Sureda A; Rocamora Durán V; Sapiña Camaró A; Royo Escosa V; Bosque López MJ
    Gastroenterol Hepatol; 2011 Oct; 34(8):546-50. PubMed ID: 21665330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab.
    Tammaro A; Persechino S; Abruzzese C; Narcisi A; Cortesi G; Parisella FR; Laganà B
    Int J Immunopathol Pharmacol; 2012; 25(2):499-501. PubMed ID: 22697082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful management of ustekinumab-induced pustular psoriasis without therapy discontinuation.
    Caca-Biljanovska N; V'lckova-Laskoska M; Laskoski D
    Acta Dermatovenerol Croat; 2013; 21(3):202-4. PubMed ID: 24183227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab-induced psoriasiform rash in rheumatoid arthritis.
    Palmou-Fontana N; Sánchez Gaviño JA; McGonagle D; García-Martinez E; Iñiguez de Onzoño Martín L
    Dermatology; 2014; 228(4):311-3. PubMed ID: 24942661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pembrolizumab-induced linear psoriasis.
    Huang PW; Chu CY
    Lung Cancer; 2020 Aug; 146():378-379. PubMed ID: 32586659
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrence of Psoriasis Vulgaris Accompanied by Treatment with C-C Chemokine Receptor Type 4 (CCR4) Antibody (Mogamulizumab) Therapies in a Patient with Adult T cell Leukemia/ Lymphoma: Insight into Autoinflammatory Diseases.
    Morichika K; Tomoyose T; Hanashiro T; Shimabukuro N; Tamaki K; Tedokon I; Nishi Y; Nakachi S; Karube KN; Fukushima T; Katoh T; Ohshima K; Masuzaki H
    Intern Med; 2016; 55(10):1345-9. PubMed ID: 27181545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.